The client achieved success with an adherence device in the consumer market and sought to expand into the pharmaceutical industry.

Their goal was to offer adherence technology as a service specifically designed to support patients in maintaining their medication schedules.

The client needed a comprehensive strategy and operating plan for establishing a new business unit focused on this pharmaceutical sector initiative.

The objective was to define a strategic focus for commercialization, pinpointing specific customer segments and assessing their needs through customer interviews to understand their values and willingness to pay (WTP).

Insights gathered from these interviews were critical in identifying what customers value most and their key needs.

Based on these insights, the task involved developing a Minimum Viable Product (MVP) tailored to meet the identified customer needs and values.

Conducted interviews with a dozen leading experts in the pharmaceutical industry, focusing on digital and data programs.

Aimed to gather insights to inform the development of an ideal product, establish appropriate pricing, and create accurate sales forecasts.

Leveraged expert knowledge to refine product strategy and align it with market expectations and needs.

Created a fully operating P&L , quantifying revenue contribution and investment to enter the Pharma market,  leading to the decision to invest in the sector and initiate business development efforts.

Facilitated over 25 meetings with prospective pharmaceutical clients to establish a foundation for the new business venture.

Established a dedicated business unit that contributed to the company's valuation, enhancing its position for the upcoming Series B fundraising round.